Software - Infrastructure · NYSE
Current Price
$10.55
PE Ratio (TTM)
16.9x
Intrinsic Value
$20.67
+49.0% margin of safety
COMPETITIVE MOAT
↑AI Orchestration Leadership
UiPath is expanding its AI orchestration capabilities, positioning itself as a leader in integrating AI into enterprise workflows. This focus aims to drive efficiency and innovation for clients.
↑Customer Success Stories
Successful implementations, like One NZ's accelerated mobile provisioning, demonstrate UiPath's ability to deliver significant operational improvements. These case studies build credibility and attract new business.
↑Security Certifications
Achieving DESC certification in Dubai enhances UiPath's credibility for public and private sector adoption of its agentic automation capabilities. This opens new markets and builds trust.
INVESTMENT RISKS
↓Intensifying Competition
UiPath faces rising competition in the AI orchestration space. This could pressure pricing and market share as other players also innovate.
↓Cautious Future Guidance
Despite accelerating revenue, the company's cautious guidance suggests potential headwinds or conservative forecasting. This can temper investor enthusiasm.
↓Stock Price Volatility
The significant year-to-date stock slide indicates investor caution and market sentiment challenges. This volatility can deter new investment.
Base case
A base case PE valuation for PATH estimates a fair value of about $20.67 per share, against a current price of $10.55. The model assumes 20.0% annual earnings growth, a 17x target PE multiple, and a 10% discount rate.
Intrinsic Value
$20.67
Margin of safety
+49.0%
Expected annual return
+14.4%
Base case assumptions: 20.0% annual earnings growth, 17x target PE, 10% discount rate, 5 year projection. Data as of 2026-06-12.
This base case uses default assumptions and is not financial advice. The fair value changes significantly when the target PE or earnings growth rate changes. Open the calculator to set your own assumptions and see the full sensitivity range.
Adjust the target PE, earnings growth, and discount rate to see how the fair value and margin of safety for UiPath Inc. respond.
Open PE Calculator for PATHUiPath Inc. delivers a comprehensive automation ecosystem, specializing in Robotic Process Automation (RPA) solutions, with a significant presence in the United States, Romania, and Japan. The company's integrated software suite empowers organizations to design, administer, execute, interact with, evaluate, and oversee their automation initiatives. This robust platform seamlessly blends artificial intelligence with features such as desktop activity recording and in-depth analysis of both human actions and system logs. Through intuitive visualization tools within a centralized portal, users can effectively discover, analyze, and identify processes ripe for automation. It provides low-code development environments, enabling personnel across an organization to create both human-assisted and fully autonomous automations without needing prior programming knowledge. These automation bots can be deployed for interactive use or run independently in the background, leveraging native connectors for integration with common line-of-business applications. UiPath also offers centralized tools for managing, testing, and deploying automations and machine learning models enterprise-wide, and supports the orchestration of complex, long-running processes that coordinate work between robots and humans. Moreover, the platform allows users to track, measure, and forecast automation performance, assisting businesses in ensuring compliance with industry standards. Beyond its core technology, the company provides essential maintenance and support services, along with professional services like training and implementation to facilitate smooth platform adoption. UiPath's diverse clientele includes entities in banking, healthcare, financial services, and government. Founded in 2005, UiPath Inc. maintains its headquarters in New York, New York.
PE Ratio (TTM)
16.9x
PEG Ratio
0.00
Earnings Yield
5.93%
ROE (TTM)
17.3%
Revenue/Share (TTM)
$3.19
Debt/Equity
0.04x
The trailing twelve-month PE ratio of PATH reflects how much investors pay per dollar of UiPath Inc.'s earnings. This metric is most useful when compared to Software - Infrastructure peers and the company's own historical range.
PATH's PE of 16.9x combined with a PEG ratio of 0.00 provides a growth-adjusted perspective. A PEG below 1.0 suggests PATH may be undervalued relative to its earnings growth rate. Keep in mind that PE-based valuation works best for profitable, mature companies — for high-growth or cyclical Software - Infrastructure, a DCF analysis may be more appropriate.
To value UiPath Inc. using PE: (1) Compare the current PE (16.9x) against the Software - Infrastructure median to assess relative pricing, (2) check the PEG ratio (0.00) to adjust for growth expectations, (3) review the 5-year PE range to identify where the stock sits historically, and (4) estimate fair value by multiplying a target PE by forward EPS estimates. This relative approach complements DCF's absolute valuation.
PATH's PEG ratio is 0.00, calculated by dividing the PE ratio (16.9x) by the expected earnings growth rate. A PEG below 1.0 is traditionally considered a sign of undervaluation — the market may not be fully pricing in the growth potential. Note that PEG accuracy depends on the reliability of growth estimates.
PE ratio gives a quick relative read — how PATH is priced versus Software - Infrastructure peers. DCF provides an absolute value based on projected free cash flows. For PATH, with a strong ROE of 17.3%, both methods are worth using — PE for a market-relative check, DCF to stress-test whether fundamentals justify the price. Each method has blind spots: PE ignores capital structure and cash flow quality, while DCF is sensitive to growth and discount rate assumptions.
P/E and DCF value PATH with different methods and assumptions, so the two conclusions can differ. Compare the DCF intrinsic value.
Price as of 2026-06-12. Financial data from Financial Modeling Prep (trailing twelve months) · Valuation methodology by Charlie Wang.
This is an estimate, not investment advice.